PMID- 34110720 OWN - NLM STAT- MEDLINE DCOM- 20220202 LR - 20240402 IS - 2051-817X (Electronic) IS - 2051-817X (Linking) VI - 9 IP - 11 DP - 2021 Jun TI - Serum MMP-3 and its association with central arterial stiffness among young adults is moderated by smoking and BMI. PG - e14920 LID - 10.14814/phy2.14920 [doi] LID - e14920 AB - Central arterial stiffness is an independent predictor of cardiovascular disease. It is characterized by a marked reduction in the elastin-collagen ratio of the arterial wall extracellular matrix (ECM), and is largely the result of degradation of various ECM components. Matrix metalloproteinase-3 (MMP-3) may contribute to central arterial stiffness via its involvement in ECM homeostasis and remodeling. This study examined the association between serum MMP-3 concentrations and central arterial stiffness and potential interactions of MMP-3 and traditional cardiovascular risk factors in a population of healthy young adults. A total of 206 participants (n = 109 females) aged 19-25 years were included in the current study. Central arterial stiffness was measured non-invasively as carotid-femoral pulse wave velocity (cfPWV) (m/s). MMP-3 concentrations (ng/ml) were measured using ELISA techniques. Regression analyses were used to examine the association between cfPWV and MMP-3, adjusting for age, sex, smoking status, body mass index (BMI), instantaneous mean arterial pressure (MAP) and heart rate, and serum C-reactive protein. Interactions between MMP-3 with smoking, BMI, sex, and MAP were analyzed in subsequent regression models. MMP-3 was an independent predictor of cfPWV (beta = 0.187, p = 0.007), and significant interactions between MMP-3 and regular smoking (beta = 0.291, p = 0.022), and MMP-3 and BMI (beta = 0.210, p = 0.013) were observed. Higher serum MMP-3 concentrations were associated with a faster cfPWV and thus, greater central arterial stiffness. Interactions between MMP-3 and smoking, and MMP-3 and BMI may, in part, drive the association between MMP-3 and central arterial stiffness. CI - (c) 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society. FAU - Iannarelli, Nathaniel J AU - Iannarelli NJ AD - Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, Saint Catharines, ON, Canada. FAU - MacNeil, Adam J AU - MacNeil AJ AD - Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, Saint Catharines, ON, Canada. FAU - Dempster, Kylie S AU - Dempster KS AD - Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, Saint Catharines, ON, Canada. AD - Brock-Niagara Centre for Health and Well-Being, Brock University, Saint Catharines, ON, Canada. FAU - Wade, Terrance J AU - Wade TJ AD - Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, Saint Catharines, ON, Canada. AD - Brock-Niagara Centre for Health and Well-Being, Brock University, Saint Catharines, ON, Canada. FAU - O'Leary, Deborah D AU - O'Leary DD AUID- ORCID: 0000-0002-0635-1536 AD - Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, Saint Catharines, ON, Canada. AD - Brock-Niagara Centre for Health and Well-Being, Brock University, Saint Catharines, ON, Canada. LA - eng GR - 363774/CIHR/Canada GR - 399332/CIHR/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Physiol Rep JT - Physiological reports JID - 101607800 RN - 9007-41-4 (C-Reactive Protein) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) SB - IM MH - Adult MH - Blood Pressure MH - *Body Mass Index MH - C-Reactive Protein/analysis MH - Female MH - Heart Disease Risk Factors MH - Heart Rate MH - Humans MH - Male MH - Matrix Metalloproteinase 3/*blood MH - Smoking/*adverse effects MH - *Vascular Stiffness/physiology MH - Young Adult PMC - PMC8191404 OTO - NOTNLM OT - arterial stiffness OT - body mass index OT - central arterial stiffness OT - matrix metalloproteinases OT - smoking COIS- The authors declare no competing interests associated with this manuscript. EDAT- 2021/06/11 06:00 MHDA- 2022/02/03 06:00 PMCR- 2021/06/10 CRDT- 2021/06/10 12:42 PHST- 2021/04/26 00:00 [revised] PHST- 2021/02/02 00:00 [received] PHST- 2021/05/14 00:00 [accepted] PHST- 2021/06/10 12:42 [entrez] PHST- 2021/06/11 06:00 [pubmed] PHST- 2022/02/03 06:00 [medline] PHST- 2021/06/10 00:00 [pmc-release] AID - PHY214920 [pii] AID - 10.14814/phy2.14920 [doi] PST - ppublish SO - Physiol Rep. 2021 Jun;9(11):e14920. doi: 10.14814/phy2.14920.